Trust Investment Advisors’s Elevance Health ELV Stock Holding History

Trust Investment Advisors’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-609	Closed	-$237K	–	114
2025 Q2	$237K	Hold	609	–	–	0.14%	91
2025 Q1	$265K	Buy	+609	New	+$244K	0.17%	84
2024 Q4	–	Sell	-509	Closed	-$265K	–	121
2024 Q3	$265K	Hold	509	–	–	0.17%	87
2024 Q2	$276K	Buy	509 +57	+13%	+$30.1K	0.18%	85
2024 Q1	$234K	Hold	452	–	–	0.17%	83
2023 Q4	$213K	Buy	+452	New	+$209K	0.17%	90
2023 Q3	–	Sell	-452	Closed	-$201K	–	102
2023 Q2	$201K	Hold	452	–	–	0.16%	94
2023 Q1	$208K	Hold	452	–	–	0.19%	96
2022 Q4	$232K	Hold	452	–	–	0.22%	86
2022 Q3	$205K	Hold	452	–	–	0.21%	86
2022 Q2	$218K	Sell	452 -307	-40%	-$152K	0.21%	84
2022 Q1	$373K	Buy	759 +307	+68%	+$140K	0.3%	76
2021 Q4	$210K	Buy	+452	New	+$190K	0.17%	87

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Trust Investment Advisors's ELV Position: Q3 2025 in Review

Trust Investment Advisors sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 609 shares — an estimated $237K sold.

Trust Investment Advisors first reported a position in ELV in Q4 2021 and held it in 13 quarters. The position peaked at $373K in Q1 2022. 1,510 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

Trust Investment Advisors reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
Trust Investment Advisors sold 609 Elevance Health shares in Q3 2025, an estimated $237K.
Trust Investment Advisors first reported a position in Elevance Health in Q4 2021 and held it in 13 quarters.
Trust Investment Advisors's Elevance Health position peaked at $373K in Q1 2022.
1,510 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on Trust Investment Advisors's 13F filing for Q3 2025, filed 24 Nov 2025.